HK Stock Market Move | IVD MEDICAL (01931) rose more than 18% during trading, Dr. Yi Xiao was appointed as the company's executive director and chief scientist.

IVD MEDICAL (01931) rose more than 18% during trading hours, and as of the time of publication, it had risen by 12.61% to 1.34 Hong Kong dollars, with a trading volume of 7.3627 million Hong Kong dollars. On the news front, on the evening of February 6th, IVD MEDICAL announced that Dr. Yi Xia, a top scientist, has been appointed as the company's executive director and chief scientist. As the executive director and chief scientist, Dr. Yi Xia will become a key hub connecting IVD MEDICAL's three curve strategies and external technology ecosystem, helping the company accurately identify high-quality technologies worldwide and ensure successful implementation in the Chinese market. The article "Reverse NewCo + Top Talent, IVD MEDICAL Reconstructs AI Medical Landscape, Dr. Yi Xia's Joining Is a Key Step" points out that IVD MEDICAL, through "Reverse NewCo," introduces global algorithms, solidifies the foundation of biobased materials and translational medicine through Dr. Yi Xia's participation, obtains clinical data and application scenarios through B-Soft Co., Ltd., and then realizes commercial implementation through its K1 distribution network. This builds a unique, complete AI medical ecosystem covering "data-algorithm-material-clinical-channel" that is difficult to replicate.